IL17A and myeloid sarcoma: Current evidence indicates that the pathogenesis of MS and EAE involves activation and differentiation of myelin-specific CD4+ T cells in peripheral lymphoid organs, particularly CD4+ IFN-γ+ Th1 cells and CD4+ IL-17+ Th17 cells [22–24].